The Minister of Health, Mr Kwaku Agyeman-Manu, says Ghana is expecting more AstraZeneca vaccines from the United Kingdom and the USA by mid-July this year to vaccinate the rest of the population against Covid-19.
So far, Ghana had received more than 800,000 doses of AstraZeneca from the COVAX Facility, MTN Africa, and the Indian government.
The Food and Drugs Authority has approved three vaccines for inoculation in Ghana: AstraZeneca, Sputnik V, and Johnson and Johnson.
However, global demand for the Covid-19 vaccines had outstripped supplies, thus, making it difficult for the government to buy vaccines from the manufacturers directly.
Mr Agyeman-Manu, at the Minister’s Media Briefing in Accra on Wednesday, said the government had signed two agreements with private dealers to supply the country with Sputnik V.
He, however, said the government only provided Letters of Credit to the dealers and would advance payments when they had delivered the vaccines on the agreed timelines.
Mr Agyeman-Manu said one of the suppliers would sell the vaccine to Ghana at US$19.00 per dose and the other one at US$18.5 and not US$26.00 as being speculated in the media.
The Minister said the government was committed to procuring more vaccines to inoculate 20 million Ghanaians, representing 60 percent of the population, to ensure herd immunity.
Meanwhile, Dr Patrick Kuma-Aboagye, the Director-General of the Ghana Health Service, said those who had taken the first jab of the AstraZeneca vaccine would still be protected from the virus beyond eight to 12 months and even up to six months. However, the antibodies would reduce by 34 percent.
He said the first dose recipients would not suffer severe health conditions or death.
Ghana has, so far, cumulatively recorded 94,619 cases, 1.2 million tests and 789 deaths from Covid-19 related ailments.
Currently, there are 1,190 active cases as of June 15, with 45 daily infections.